Eating disorder not otherwise specified an especially prevalent category in populations that have received inadequate research attention such as young children, males, ethnic minorities, and non-Western groups. Eating disorder not otherwise specified Eating disorder not otherwise specified (EDNOS) is an eating disorder that is no longer recognized in the most recent version of the "Diagnostic and Statistical Manual of Mental Disorders" (DSM). In 2013, it was replaced by other specified feeding or eating disorder (OSFED) in DSM-5. Eating disorder not otherwise specified is an eating disorder that does not meet the criteria for: anorexia nervosa or bulimia nervosa. Individuals with EDNOS usually fall into one
Binge eating disorder is used for the treatment of moderate to severe binge eating disorder in adults. Three other classes of medications are also used in the treatment of binge eating disorder: antidepressants, anticonvulsants, and anti-obesity medications. Antidepressant medications of the selective serotonin reuptake inhibitor (SSRI) class such as fluoxetine, fluvoxamine, or sertraline have been found to effectively reduce episodes of binge eating and reduce weight. Similarly, anticonvulsant medications such as topiramate and zonisamide may be able to effectively suppress appetite. The long-term effectiveness of medication for binge eating disorder is currently unknown. Trials of antidepressants, anticonvulsants, and anti-obesity medications suggest that these